Clin2
NCT03804931Possibly a fitRecruiting

Stool transplant for moderate to severe ulcerative colitis

Ulcerative ColitisFecal Microbiota Transplantation

Treatments studied

Part of Digestive system clinical trials.

This trial tests whether transplanting stool bacteria into the colon (fecal microbiota transplantation) can improve ulcerative colitis symptoms in people with active, moderate to severe disease. If you qualify, the study team will also check that it’s safe for you and that you can safely undergo a scope exam.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
120 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You have active ulcerative colitis that is moderate to severe (Mayo score over 6).
  • You have previously used 5-ASA medicine and have no major safety concerns from it.
  • You can safely have an endoscopy exam (a flexible camera procedure of the colon).
  • You have not used antibiotics in the last 7 days.
  • You do not have a dangerous complication called toxic megacolon.
  • You do not have colon cancer or other abnormal growths in the colon.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04706611Recruiting
Stool transplant to treat gut and immune-related conditions

This trial studies fecal microbiota transplantation (a stool-based treatment) to improve symptoms and safety in people with certain gut and immune conditions. It aims to see whether changing gut bacteria can help you feel better.

Guangzhou, Guangdong
NCT04014413Recruiting
Fecal transplant for gut and immune-related conditions

This trial studies whether fecal microbiota transplantation (FMT)—a medical procedure using stool from a screened donor to restore gut bacteria—can improve safety and outcomes for people with certain bowel, immune, and metabolic conditions. It may help if your symptoms are thought to be related to an unhealthy gut microbiome, though eligibility is broad and depends on specific safety factors.

Hong Kong, Shatin
NCT07154784Enrolling by invitation· Phase 2/Phase 3
Fecal transplant for long-term ulcerative colitis treatment

This trial tests whether fecal microbiota transplantation (FMT) can safely and effectively treat mild to moderate ulcerative colitis over the long term. FMT involves transferring stool from a healthy donor to restore a healthy balance of gut bacteria.

Seoul, Dongjak-gu
NCT07401680Recruiting· Phase 1
Stool transplant for active ulcerative colitis

This trial tests whether a stool transplant (fecal microbiota transplantation) can help manage active ulcerative colitis. You would receive a transplant from a healthy donor to see if it improves your symptoms.

Calgary, Alberta
NCT05679622Recruiting
Stool transplant study for children with mild to moderate ulcerative colitis

This trial studies whether transferring healthy stool bacteria into the gut (fecal microbiota transplantation, or FMT) can improve symptoms in children with ulcerative colitis. It may help by changing gut bacteria, especially for children who are newly diagnosed or who didn’t respond to standard treatments.

Wuhan
NCT06906445Recruiting
Fecal transplant and diet changes for ulcerative colitis

This trial tests if a fecal transplant combined with dietary changes can help control symptoms in people with active ulcerative colitis who haven't responded well to standard treatments or advanced therapies.

Kochi, Kerala

Hear when a new Ulcerative Colitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.